Balanced news tone
News Sentiment
EUDA sentiment intelligence
EUDA Health Holdings Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
59 relevant articles
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-18.9% over one week, -25.9% over four weeks, trend inactive, and below fair value.
12 Health Care Stocks Moving In Friday's Intraday Session
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
84/100 classification
One-week reaction
-18.9%
Price reacting lower
Trend fit
Trend inactive
-25.9% over four weeks
Fair value
-76.7%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
12
Neutral
39
Negative
8
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
StockStory
Industry context
Q1 Earnings Roundup: The Real Brokerage (NASDAQ:REAX) And The Rest Of The Consumer Discretionary - Real Estate Services Segment
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jul 2026 10:53
- Source
- StockStory
Benzinga
Direct company coverage
12 Health Care Stocks Moving In Friday's Intraday Session
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 17:05
- Source
- Benzinga
Intellectia AI
Direct company coverage
EUDA PE Ratio & Valuation, Is EUDA Overvalued
This article analyzes the valuation of EUDA Health Holdings Ltd (EUDA), noting its current classification as "Undervalued." Key metrics such as the forward PS ratio, P/B ratio, and FCF yield are examined against historical averages and competitor benchmarks, revealing discrepanci
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 10 Jul 2026 04:11
- Source
- Intellectia AI
Ad-hoc-news.de
Direct company coverage
EUDA stock holds the spotlight. Thin source set keeps the focus on the business
The article discusses EUDA Health Holdings Ltd. (US29821P1030), a US-listed healthcare company focusing on health and wellness services. Despite a thin source set, the article confirms the company's identity and business model, allowing for publishable coverage. It emphasizes tha
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 13:17
- Source
- Ad-hoc-news.de
dars.gov.et
Direct company coverage
EUDA Health Holdings (EUDA) Surges 5.6% as Bullish Momentum Builds - Fibonacci Entry Signals
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- dars.gov.et
Moomoo
Direct company coverage
EUDA Health Company Profile & Introduction
This article provides a company profile and introduction for EUDA Health. It serves as a foundational overview of the company, likely detailing its mission, services, and market position.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 15:10
- Source
- Moomoo
Market source
Industry context
Consumer Discretionary - Real Estate Services Q1 Earnings: Howard Hughes Holdings (NYSE:HHH) Simply the Best
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Jun 2026 07:00
- Source
- Market source
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of EUDA Health Holdings Ltd (EUDA), detailing its price momentum score of 6.84 and suggesting it's suitable for range-bound swing trading with support at $12.85 and resistance at $17.55. It further presents a breakdown of technical indic
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 22 Jun 2026 08:41
- Source
- TradingKey
Market source
Industry context
Q1 Earnings Highs And Lows: Newmark (NASDAQ:NMRK) Vs The Rest Of The Consumer Discretionary - Real Estate Services Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Jun 2026 07:00
- Source
- Market source
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDAW) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of the dividend and stock split history for EUDA Health Holdings Ltd (EUDAW). It states that no dividends have been distributed over the past five years and no stock split data is available. The page includes current stock price information and l
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 19 Jun 2026 02:20
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDA) Institutional Confidence
This article provides an "Institutional Confidence" overview for EUDA Health Holdings Ltd (EUDA) as of June 18, 2026. It lists key institutional shareholders, their shareholdings, and changes in their positions. The company's stock price, market capitalization, and a general over
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 18:09
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for EUDA Health Holdings Ltd (EUDA), detailing its financial performance by region. As of the last update on Monday, April 6, the company generated $3.92 million from Singapore, accounting for 97.78% of its revenue, and $89.02K from Malay
- Tone
- Negative 31/100
- Event
- Earnings
- Published
- 18 Jun 2026 06:40
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDA) Earnings Forecast: Future EPS & Revenue Growth Estimates
The article provides an earnings forecast for EUDA Health Holdings Ltd (EUDA), noting its current earnings forecast score of 8.00 and ranking 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $6.00 for EUDA, with one analyst recomm
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 18 Jun 2026 05:40
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDA) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of EUDA Health Holdings Ltd (EUDA), noting its current valuation score of 8.97, ranking 55th in the Healthcare Equipment & Supplies industry. It highlights EUDA's current P/E ratio of -11.11, while stating that relevant data for P/B, P/S
- Tone
- Negative 41/100
- Event
- Market update
- Published
- 18 Jun 2026 05:40
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDAW) Financial Health: Profitability & Balance Sheet Analysis
This article provides a financial health analysis of EUDA Health Holdings Ltd (EUDAW), focusing on profitability and balance sheet aspects. It notes that a significant amount of relevant financial data has not yet been disclosed by the company, including key metrics for quality o
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:40
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDAW) Institutional Confidence
This article from TradingKey provides an overview of EUDA Health Holdings Ltd (EUDAW)'s institutional confidence, detailing the shares held by various investment firms. It lists several key institutional shareholders and their changes in shareholding percentage, such as AQR Arbit
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:40
- Source
- TradingKey
TradingKey
Direct company coverage
EUDA Health Holdings Ltd (EUDAW) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of EUDA Health Holdings Ltd (EUDAW), including support, resistance, indicators, and moving averages. While specific support and resistance data are not disclosed, the analysis covers various technical indicators like MACD, RSI, and KDJ,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:40
- Source
- TradingKey
Stock Titan
Direct company coverage
EUDA Health (NASDAQ: EUDA) suspends ATM offering, files termination notice
EUDA Health has suspended its At-The-Market (ATM) offering and is terminating its ATM Agreement, reducing the maximum aggregate offering price to $10.0 million. No ordinary shares were sold under the ATM Agreement as of the supplement date. The termination process was initiated o
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 10:40
- Source
- Stock Titan
Stock Titan
Direct company coverage
EUDA (EUDA) suspends and terminates $10M at-the-market share offering with Chardan
EUDA Health Holdings Limited has announced the suspension and termination of its $10 million at-the-market (ATM) equity offering program with Chardan Capital Markets LLC. The company sent a termination notice on June 5, 2026, with the termination becoming effective on July 22, 20
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 14:40
- Source
- Stock Titan
Stock Titan
Direct company coverage
[6-K] EUDA Health Holdings Ltd Current Report (Foreign Issuer)
EUDA Health Holdings Limited has announced the suspension of its At The Market (ATM) Offering, effective June 10, 2026, and the termination of its ATM Agreement with Chardan Capital Markets LLC. The termination will be effective after July 22, 2026, following a 30-business-day no
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 10 Jun 2026 11:39
- Source
- Stock Titan
Stock Titan
Direct company coverage
Tan Meng Dong holds 15.3% of EUDA (NASDAQ: EUDA) in amended Schedule 13G
An amended Schedule 13G filing reveals that Tan Meng Dong, through direct and indirect holdings including 8i Capital Limited and warrants, beneficially owns 459,130 ordinary shares of EUDA Health Holdings Ltd (NASDAQ: EUDA), representing 15.3% of the company's outstanding shares.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 01:40
- Source
- Stock Titan
Stock Titan
Direct company coverage
Zhang Xin reports 295,000 shares in EUDA (EUDA) — 9.85% stake
Zhang Xin has reported a 9.85% stake in EUDA Health Holdings Ltd (EUDA) through a Schedule 13G filing. This beneficial ownership amounts to 295,000 ordinary shares, representing sole voting and dispositive power. The percentage calculation is based on 2,994,325 ordinary shares ou
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 Jun 2026 20:39
- Source
- Stock Titan
Market source
Direct company coverage
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
EUDA Health Holdings Limited has expanded its Helixé product line by launching the Regenixé iPSC-derived Skin Stem Cell Secretome Mask. This new beauty product, developed by Chemokine Pte Ltd, aims to support skin hydration and brightening. EUDA Health, which holds exclusive glob
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 04 Jun 2026 12:39
- Source
- Market source
MSN
Direct company coverage
EUDA Health regains Nasdaq compliance after meeting minimum market value standards
EUDA Health has successfully regained compliance with Nasdaq's minimum market value requirements. This achievement follows the company demonstrating that its market capitalization met the necessary standards for continued listing on the stock exchange.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 11:39
- Source
- MSN
MT Newswires
Direct company coverage
EUDA Health Regains Nasdaq Minimum Market Value Compliance, Expands Product Line
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 01 Jun 2026 11:56
- Source
- MT Newswires
Stock Titan
Direct company coverage
EUDA Health (NASDAQ: EUDA) debuts Regenixé stem cell secretome mask
EUDA Health Holdings Limited has launched the Regenixé iPSC-derived Skin Stem Cell Secretome Mask, expanding its Helixé product line. This premium beauty mask, developed by Chemokine Pte Ltd, aims to support skin hydration, brightening, and recovery, with EUDA holding exclusive g
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 01 Jun 2026 12:40
- Source
- Stock Titan
Caledonian Record
Direct company coverage
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell ...
EUDA Health Holdings Limited announced the launch of Regenixé iPSC-derived Skin Stem Cell Secretome Mask, expanding its Helixé product line. This beauty product, developed by Chemokine Pte Ltd, aims to support skin hydration, brightening, and overall recovery. EUDA Health has exc
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 01 Jun 2026 12:09
- Source
- Caledonian Record
Stock Titan
Direct company coverage
EUDA Health (NASDAQ: EUDA) regains Nasdaq MVLS listing compliance
EUDA Health Holdings Limited (NASDAQ: EUDA) has announced it has regained compliance with the Nasdaq Capital Market's continued listing requirements regarding market value. The company previously received a notice on April 23, 2026, for failing to maintain a minimum market value
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 11:40
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 10:00
- Source
- GlobeNewswire
Investing.com Canada
Direct company coverage
EUDA Health expands product line with new stem cell mask By Investing.com
EUDA Health Holdings Limited has launched its Regenix iPSC-derived Skin Stem Cell Secretome Mask, expanding its Helix product line. The company, which holds exclusive global distribution rights for Helix products, plans to distribute the new mask across the Asia-Pacific region, p
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 01 Jun 2026 10:40
- Source
- Investing.com Canada